CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

Historical Holders from Q1 2014 to Q1 2025

Symbol
CPRX on Nasdaq
CUSIP
14888U101
Type / Class
Equity / Common Stock
Shares outstanding
119M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
97.4M
Holdings value
$2.03B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
332
Number of buys
183
Number of sells
-125
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flynn James E 2.63% $76M 3.13M Deerfield Mgmt, L.P. Dec 31, 2024

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.82M $44M +$9.24M $24.25 46
2024 Q4 97.4M $2.03B +$40.6M $20.87 332
2024 Q3 95.3M $1.89B -$37.3M $19.88 310
2024 Q2 97M $1.5B +$14M $15.49 268
2024 Q1 96.1M $1.53B +$192M $15.94 267
2023 Q4 82.5M $1.39B +$45.2M $16.81 256
2023 Q3 81.1M $949M -$23.7M $11.69 252
2023 Q2 82.2M $1.1B -$95.3M $13.44 241
2023 Q1 88.8M $1.47B +$71M $16.58 255
2022 Q4 84M $1.56B -$9.96M $18.60 250
2022 Q3 82.1M $1.05B +$185M $12.83 215
2022 Q2 73.8M $515M +$38.3M $7.01 170
2022 Q1 67.7M $561M +$34.5M $8.29 176
2021 Q4 65.3M $442M +$3.78M $6.77 157
2021 Q3 65.1M $345M -$1.8M $5.30 138
2021 Q2 65.3M $376M -$10.2M $5.75 136
2021 Q1 67.6M $312M +$11.3M $4.61 131
2020 Q4 66.6M $222M -$12.7M $3.34 130
2020 Q3 67.9M $202M +$814K $2.97 138
2020 Q2 64.7M $299M -$3M $4.62 136
2020 Q1 63.1M $243M +$12.2M $3.85 126
2019 Q4 60M $225M -$31.6M $3.75 125
2019 Q3 61.5M $327M +$8.44M $5.31 114
2019 Q2 61.5M $236M -$4.81M $3.84 98
2019 Q1 61.5M $314M +$64.1M $5.10 86
2018 Q4 49.1M $94.2M -$22M $1.92 83
2018 Q3 51M $193M -$11.4M $3.78 94
2018 Q2 54M $169M +$2.66M $3.12 96
2018 Q1 54.7M $131M -$11.1M $2.39 96
2017 Q4 56.1M $219M +$80.4M $3.91 105
2017 Q3 35.6M $89.6M +$4.34M $2.52 76
2017 Q2 33.9M $93.7M +$24.7M $2.76 67
2017 Q1 25.3M $49.3M +$4.79M $1.95 51
2016 Q4 23.8M $25M +$503K $1.05 49
2016 Q3 23.3M $25.4M -$1.71M $1.09 45
2016 Q2 25.4M $18M -$12.3M $0.71 56
2016 Q1 36.9M $43.2M -$15.8M $1.17 70
2015 Q4 42.3M $104M -$6.36M $2.45 84
2015 Q3 44.7M $134M +$1.58M $3.00 88
2015 Q2 43.3M $179M +$18.6M $4.13 85
2015 Q1 38.8M $168M +$54.5M $4.33 64
2014 Q4 27.2M $80.7M +$8.34M $2.97 48
2014 Q3 23.5M $78M +$8.08M $3.32 51
2014 Q2 22.2M $56.1M +$29.9M $2.53 45
2014 Q1 10.3M $23.4M +$2.87M $2.26 35